awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38012156-094EA0B2-2DE5-49C8-9AAD-576B5C85599E
Q38012156-094EA0B2-2DE5-49C8-9AAD-576B5C85599E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012156-094EA0B2-2DE5-49C8-9AAD-576B5C85599E
Sorafenib in locally advanced or metastatic breast cancer.
P2860
Q38012156-094EA0B2-2DE5-49C8-9AAD-576B5C85599E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012156-094EA0B2-2DE5-49C8-9AAD-576B5C85599E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b297d69d9763c5a34f938768b5c44a3bec989f1
P2860
Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors.